Masimo Corporation
MASI
Rank in Stocks
#2169
Masimo Corporation engages in the development, manufacture, and marketing of... Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.
Share Price
$179.95
Last synced: 2026-06-12
Market Cap
$9.42B
Change (1 day)
0.00%
Change (1 year)
22.41%
Country
US
Trade Masimo Corporation (MASI)
Category
Healthcare
Revenue for Masimo Corporation (MASI)
Revenue in Apr 2026 TTM: $1.56B
According to Masimo Corporation latest financial reports the company's current revenue (TTM) is $1.56B. In 2023 the company made a revenue of $2.05B an increase over the revenue in the year 2022 that was $2.04B. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Masimo Corporation from 2002 to 2026
Revenue at the end of each year
| Year | Revenue | Change |
|---|---|---|
| 2026 (TTM) | $1.56B | -25.59% |
| 2024 | $2.09B | 2.26% |
| 2023 | $2.05B | 0.60% |
| 2022 | $2.04B | 64.28% |
| 2021 | $1.24B | 8.35% |
| 2020 | $1.14B | 21.95% |
| 2019 | $937.84M | 9.27% |
| 2018 | $858.29M | 8.61% |
| 2017 | $790.25M | 10.85% |
| 2016 | $712.90M | 13.14% |
| 2015 | $630.11M | 7.41% |
| 2014 | $586.64M | 7.20% |
| 2013 | $547.25M | 10.95% |
| 2012 | $493.23M | 12.36% |
| 2011 | $438.99M | 8.28% |
| 2010 | $405.41M | 16.12% |
| 2009 | $349.12M | 13.69% |
| 2008 | $307.07M | 19.82% |
| 2007 | $256.29M | 14.24% |
| 2006 | $224.34M | 107.93% |
| 2005 | $107.89M | 55.56% |
| 2004 | $69.36M | 48.41% |
| 2003 | $46.73M | 20.35% |
| 2002 | $38.83M | 0.00% |
Revenue for similar companies or competitors
| Company | Revenue | Revenue Difference | Country |
|---|---|---|---|
| $46.59B | 2,889.09% |
US
|
|
| $35.48B | 2,176.80% |
IE
|
|
| $25.84B | 1,557.81% |
US
|
|
| $21.00B | 1,247.19% |
US
|
|
| - | - |
DE
|
